SELLAS Life Sciences Group, Inc. Profile Avatar - Palmy Investing

SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunot…

Biotechnology
US, New York [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of SLS's Analysis
CIK: 1390478 CUSIP: 81642T209 ISIN: US81642T2096 LEI: - UEI: -
Secondary Listings
SLS has no secondary listings inside our databases.